Recurrent Ovarian High Grade Serous Adenocarcinoma

specific

The reemergence of ovarian high-grade serous adenocarcinoma after a period of remission.

41

Centers

57

Active Trials

Cancer Funding

Top Centers for Recurrent Ovarian High Grade Serous Adenocarcinoma(41)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.6
2
High-Volume Research Center
72.6
3
NCI Comprehensive
Active Research Program
64.9
4
NCI Comprehensive
Active Research Program
64.9
5
NCI Comprehensive
Active Research Program
64.9
6
NCI Comprehensive
Active Research Program
64.9
7
NCI Clinical
Active Research Program
64.9
8
Active Research Program
64.9
9
Active Research Program
64.9
10
NCI Comprehensive
Active Research Program
64.9
11
NCI Comprehensive
Active Research Program
64.9
12
Active Research Program
64.9
13
Active Research Program
64.9
14
Active Research Program
64.9
15
NCI Comprehensive
Active Research Program
43.5
16
NCI Comprehensive
Active Research Program
43.5
17
NCI Comprehensive
Active Research Program
43.5
18
NCI Comprehensive
Active Research Program
43.5
19
NCI Comprehensive
Active Research Program
43.5
20
NCI Comprehensive
Active Research Program
43.5
21
NCI Comprehensive
Active Research Program
43.5
22
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
43.5
23
NCI Comprehensive
Active Research Program
43.5
24
NCI Comprehensive
Active Research Program
43.5
25
NCI Comprehensive
Active Research Program
43.5
26
NCI Comprehensive
Active Research Program
43.5
27
NCI Comprehensive
Active Research Program
43.5
28
NCI Comprehensive
Active Research Program
43.5
29
NCI Clinical
Active Research Program
43.5
30
NCI Comprehensive
Active Research Program
43.5
31
NCI Clinical
Active Research Program
43.5
32
Active Research Program
43.5
33
NCI Comprehensive
Active Research Program
43.5
3443.5
35
Active Research Program
43.5
36
Active Research Program
43.5
37
Active Research Program
43.5
3843.5
39
Active Research Program
43.5
40
Active Research Program
43.5
41
Active Research Program
43.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →